Loading clinical trials...
Loading clinical trials...
This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating signs and symptoms and improving physical function in Chinese patients with active psoriatic arthritis and...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07486960 · Psoriatic Arthritis
NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more
NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more
NCT04876781 · Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis, and more
NCT07295509 · Psoriatic Arthritis
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui
Anhui Provincial Hospital
Hefei, Anhui
The First Affiliated Hospital of Anhui Medical University/Rheumatology Department
Hefei, Anhui
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions